The effects of oscillating positive expiratory pressure therapy in adults with stable non-cystic fibrosis bronchiectasis: A systematic review

Chronic Respiratory Disease

Volumn 12, Issue 1, 2015, Pages 36-46

  Lee, Annemarie L ^a,b   Williamson, Hannah C ^b   Lorensini, Sarah ^c   Spencer, Lissa M ^d,e  

^a ALFRED HEALTH   (Australia)

^b AUSTIN HEALTH   (Australia)

^c Adelaide Community Healthcare Alliance Health   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

airway clearance therapy; non cystic fibrosis bronchiectasis; Oscillating positive expiratory pressure therapy; systematic review

Indexed keywords

ARTICLE; BREATHING; BRONCHIECTASIS; COUGHING; DISEASE EXACERBATION; DYSPNEA; GAS EXCHANGE; HEMOPTYSIS; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; LUNG CLEARANCE; LUNG FUNCTION; LUNG VOLUME; META ANALYSIS; NONCYSTIC FIBROSIS BRONCHIECTASIS; OSCILLATING POSITIVE EXPIRATORY PRESSURE; OXIMETRY; POSITIVE END EXPIRATORY PRESSURE; POSTURAL DRAINAGE; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; SPUTUM; SYMPTOM; SYSTEMATIC REVIEW; ADULT; ARTIFICIAL VENTILATION; CHEST WALL OSCILLATION; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; PROCEDURES; TREATMENT OUTCOME;

ADULT; BRONCHIECTASIS; CHEST WALL OSCILLATION; HUMANS; POSITIVE-PRESSURE RESPIRATION; PULMONARY GAS EXCHANGE; RESPIRATORY FUNCTION TESTS; RESPIRATORY THERAPY; TREATMENT OUTCOME;

EID: 84921478589     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972314562407     Document Type: Article

References (43)

1. Barker A. Bronchiectasis. New Engl J Med. 2002 ; 346: 1383-393
2. King P, Holdsworth S, Freezer N, et al. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med. 2006 ; 100: 2183-2189
3. Wilson C, Jones P, O'Leary C, et al. Validation of the St George's respiratory questionnaire in bronchiectasis. Am J Respir Crit Care Med. 1997 ; 156: 536-541
4. Martinez-Garcia M, Perpina-Tordera M, Roman-Sanchez P, et al. Quality of life determinants in patients with clinically stable bronchiectasis. Chest. 2005 ; 128: 739-745
5. Martinez-Garcia M, Perpina-Tordera M, Soler-Cataluna J, et al. Dissociation of lung function, dyspnea ratings and pulmonary extension in bronchiectasis. Respir Med. 2007 ; 101: 2248-2253
6. Pasteur M, Bilton D, Hill A. British thoracic society guidelines for non-CF bronchiectasis. Thorax. 2010 ; 65 ((Suppl. 1)). i1 - i58
7. Chang AB, Bell SC, Byrnes CA, et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. A position statement from the thoracic society of Australia and New Zealand and the Australian Lung Foundation. Med J Aust. 2010 ; 193: 356-365
8. Chang AB, Grimwood K, Maguire G, et al. Management of bronchiectasis and chronic suppurative lung disease in indigenous children and adults from rural and remote Australian communities. Med J Aust. 2008 ; 189: 386-393
9. Bott J, Blumenthal S, Buxton M, et al. Physiotherapy management of the medical respiratory patient: the adult spontaneously breathing patient. Thorax. 2 009 ; 64 ((Suppl. 1)). i25 - i31
10. Flude L, Agent P, Bilton D. Chest physiotherapy techniques in bronchiectasis. Clin Chest Med. 2012 ; 33: 351-361
11. Lee AL, Burge A, Holland A. Airway clearance techniques in bronchiectasis. Cochrane Database Syst Rev. 2013 ; 5 :
12. Lee AL, Button B, Denehy L. Current physiotherapy practice in Australia and New Zealand for patients with chronic obstructive pulmonary disease and bronchiectasis. New Zeal J Physiother. 2008 ; 32: 49-58
13. O'Neil B, Bradley J, McArdle N, et al. The current physiotherapy management of patients with bronchiectasis: a UK survey. Int J Clin Pract. 2002 ; 56: 34-35
14. Butler S, Hill LJ, Harrison J, et al. Is there a difference in airway clearance practices between children with non cystic fibrosis bronchiectasis and cystic fibrosis. New Zeal J Physiother. 2008 ; 36: 112-117
15. App E, Kieselmann R, Reinhardt D, et al. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage. Chest. 1998 ; 114: 171-177
16. Tambascio J, de Souza L, Lisboa R, et al. The influence of Flutter VRP1 components on mucus transport of patients with bronchiectasis. Respir Med. 2011 ; 105: 1316-1321
17. Ramos E, Ramos D, Lyomasa C, et al. Influencia da tecnica de pressao expiratoria positiva oscilante utilizando pressoes expiratorias pre-determinadas na viscosidade e na transportabilidade do escarro em pacientes com bronquiectasia. J Bas Pneum. 2009 ; 35: 1190-1197
18. Volsko TA, DiFiore J, Chatburn RL. Performance comparison of two oscillating positive expiratory pressure devices: acapella versus flutter. Respir Care. 2003 ; 48: 124-130
19. Guimaraes F, Moco V, Menezes S, et al. Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revi Brasi Fisiote. 2012 ; 16: 108-113
20. Patterson J, Bradley J, Hewitt O, et al. Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques versus Acapella. Respiration. 2 005 ; 72: 239-242
21. Thompson C, Harrison S, Ashley J, et al. Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis. Thorax. 20 02 ; 57: 446-448
22. Eaton T, Young P, Zeng I, et al. A randomized evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non-cystic fibrosis bronchiectasis. Chron Respir Dis. 2007 ; 4: 23-30
23. Cochrane consumers and communication review group. Data extraction template for Cochrane Reviews. 2013, http://www.cccrg.cochrane.org/sites/cccrg.cochrane.org/files/... /DET-2013-0.doc(accessed June 2013).
24. Centre for Evidence-based physiotherapy, http://www.pedro.fhs.usyd.edu.au/scale-item.html (accessed August 2013).
25. Downs S, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Comm Health. 1998 ; 52: 377-384
26. Ng L, Mackney J, Jenkins S, et al. Does exercise training change physical activity in people with COPD? A systematic review and meta-analysis. Chron Respir Dis. 2012 ; 9: 17-26
27. Portney LG, Watkins MP Foundations of clinical research, applications to practice. 3 rd ed. Upper Saddle River: Pearson/Prentice Hall, 2009. Upper Saddle River: Pearson/Prentice Hall ; 2009 :
28. Moher D, Dulberg CS, Wells GA. Statistica power, sample size and their reporting in randomised controlled trials. JAMA. 1994 ; 272: 122-124
29. Murray M, Pentland J, Hill A. A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis. Eur Respir J. 2009 ; 34: 1086-1092
30. Naraparaju S, Vaishali K, Venkatsean P, et al. A comparison of the Acapella and a threshold inspiratory muscle trainer for sputum clearance in bronchiectasis: a pilot study. Physiother Theory Pract. 2010 ; 26: 353-357
31. Figueiredo P, Zin W, Guimaraes F. Flutter valve improves respiratory mechanics and sputum production in patients with bronchiectasis. Physiother Res Int. 2012 ; 17: 12-20
32. Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982 ; 14: 377-381
33. Prasad S, Randall S, Balfour-Lynn I. Fifteen-count breathlessness score: an objective measure for children. Ped Pulmonol. 2000 ; 30: 56-62
34. Patterson J, Bradley J, Elborn J. Airwy clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques (incorporating postural drainage and vibration) versus test of incremental respiratory endurance. Chron Respir Dis. 2004 ; 1: 127-130
35. Elkins MR, Jones A, Schans C. Positive expiratory presssure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database Syst Rev. 2004 ; ( 1 ):
36. Mazzocco M, Owens G, Kirilloff L, et al. Chest percussion and postural drainage in patients with bronchiectasis. Chest. 1985 ; 88: 360-363
37. Smith M, Hill A. Evaluating success of therapy for bronchiectasis: what end points to use?. Clin Chest Med. 2012 ; 33: 329-349
38. Cochrane G, Webber B, Clarke S. Effect of sputum on pulmonary function. Brit Med J. 1977 ; 2 ((6096)). 1181-1183
39. Roberts H, Wells A, Milne D, et al. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax. 2000 ; 55: 198-204
40. Kang E, Miller R, Muller N. Bronchiectasis: comparison of preoperative thin-section CT and pathologic findings in resected specimens. Radiol. 1995 ; 195: 649-654
41. Horsley A, Gustafsson P, Macleod K, et al. Lung clearance index is a sensitive, repeatable and practical measure of airway disease in adults with cystic fibrosis. Thorax. 2008 ; 63: 135-140
42. Finklea J, Khan G, Thomas S, et al. Predictors of mortality in hospitalised patients with acute exacerbation of bronchiectasis. Respir Med. 2010 ; 104: 816-821
43. Martinez-Garcia M, Soler-Cataluna J, Perpina-Tordera M, et al. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest. 2007 ; 132: 1565-1572